This is the authors' abstract. We don't add key points for this paper.
Huntington’s disease (HD) is an inherited, incurable disease caused by a mutation and expansion of CAG repeats in the HTT gene encoding the huntingtin protein (mHTT). Despite numerous studies conducted on various cellular and animal models, specific mechanisms explaining the biological role of mHTT and its toxicity to striatal neurons have not yet been established, and effective therapy for patients has not been developed. We obtained and characterized a new line of dermal fibroblasts HDDF (Huntington Disease Dermal Fibroblasts) from a patient with a confirmed diagnosis of HD. The growth characteristics of the HDDF line, staining for canonical markers, karyotyping and cell phenotyping were performed. Direct differentiation of fibroblasts from the resulting line into induced striatal neurons was carried out. The new fibroblast line can be used as a cell model to study the biological role of mHTT and various manifestations of HD pathogenesis both in fibroblasts themselves and in induced neuronal cells obtained using reprogramming methods.
No takes yet. Share an insight, caveat, or question.
Kraskovskaya et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: